Lat­est news on first-ever Lag-3 OK; Aduhelm sup­port, crit­i­cism both crescen­do; Phar­ma gets firm about Rus­sia; Set­backs mar top R&D prospects; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

We are keep­ing in close touch with our col­leagues in Ukraine, who are al­ways in our thoughts. For those of you who have friends or fam­i­ly af­fect­ed by this war, we share your wish that they will find peace and re­unite with loved ones soon.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.